Stanley Laman Group, Ltd. Aurinia Pharmaceuticals Inc. Transaction History
Stanley Laman Group, Ltd.
- $652 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding AUPH
# of Institutions
227Shares Held
58.9MCall Options Held
949KPut Options Held
1.51M-
Black Rock Inc. New York, NY9.27MShares$75.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA8.43MShares$68.8 Million5.69% of portfolio
-
Armistice Capital, LLC New York, NY6.4MShares$52.2 Million0.81% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$32.4 Million2.55% of portfolio
-
State Street Corp Boston, MA2.92MShares$23.8 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $1.16B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...